Grace Cherry
Hematology & Oncology · Los Angeles, CANPI 1659306447
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $60,468 of the $99,486 with a category attached, or 60.8%. Regeneron Healthcare Solutions, Inc. accounts for 86.1% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2024 at $29,419 and has fallen 68.5% since, to $9,268 in 2025. Among hematology & oncology clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 237 payments — averaging $419.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Regeneron Healthcare Solutions, Inc.$86K
- Sanofi$9K
- Immunocore Limited$4K
- Novartis$732
- Seagen Inc.$124
- Delcath Systems$123
- plus $138 from 2 others
What the payments were for
- Consulting fees$3,1323%
- Speaking & faculty fees$60,46861%
- Travel & lodging$31,81232%
- Food & beverage$4,0744%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 203 | $85,685 |
| Sanofi | 17 | $8,786 |
| Immunocore Limited | 10 | $3,900 |
| Novartis | 1 | $732 |
| Seagen Inc. | 1 | $124 |
| Delcath Systems | 2 | $123 |
| AstraZeneca | 1 | $102 |
| Array Biopharma Inc | 2 | $36 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$99,486 in reported general payments places this provider in the 90th percentile of 1,363 hematology & oncology providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocortisone | 15 | $447 |
| Pantoprazole Sodium | 12 | $186 |
| Triamcinolone Acetonide | 11 | $153 |
| Prednisone | 23 | $101 |
| Hydroxyzine Hcl | 15 | $100 |
Paid to pharmacies, not to this prescriber.
Other hematology & oncology in Los Angeles
- Dennis SlamonLos Angeles$3.1M
- George YaghmourLos Angeles$1.9M
- Kevin KellyLos Angeles$894K
- Raghuveer RanganathanLos Angeles$609K
- Matthew RettigLos Angeles$442K
- David BerzLos Angeles$420K
- Gottfried KonecnyLos Angeles$402K
- Antoni RibasLos Angeles$315K
- Edward GaronLos Angeles$301K
- Rahul NaikLos Angeles$297K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.